SOAT1 Inhibitors

SOAT1 inhibitors belong to a chemical class of compounds that specifically target and inhibit the activity of the enzyme Sterol O-acyltransferase 1 (SOAT1). SOAT1, also known as Acyl-CoA cholesterol acyltransferase 1 (ACAT1), is a key enzyme involved in cholesterol metabolism. It plays a crucial role in esterifying free cholesterol to form cholesteryl esters, which are then stored in lipid droplets. This process is critical for cholesterol homeostasis and cellular lipid balance. Inhibiting SOAT1 can potentially impact cholesterol metabolism and related pathways, making it a topic of interest in research related to metabolic disorders, particularly those involving cholesterol dysregulation.

SOAT1 inhibitors are designed to selectively bind to the active site of the SOAT1 enzyme, preventing its catalytic function. By inhibiting SOAT1, these compounds aim to reduce the formation of cholesteryl esters, which may lead to alterations in cellular lipid profiles and cholesterol storage. This can have implications for cholesterol-related diseases, such as atherosclerosis and dyslipidemia. Additionally, inhibiting SOAT1 might also influence other cellular processes and signaling pathways associated with lipid metabolism and cellular lipid droplet dynamics.